XPONANCE, INC. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 299 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
XPONANCE, INC. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$210,547
-11.5%
5,163
+21.5%
0.00%
-40.0%
Q3 2022$238,000
+13.9%
4,250
+5.2%
0.01%
+25.0%
Q2 2022$209,000
-12.9%
4,040
+22.1%
0.00%0.0%
Q1 2022$240,000
-38.3%
3,308
+0.4%
0.00%
-33.3%
Q4 2021$389,000
-10.8%
3,294
+1.4%
0.01%
-25.0%
Q3 2021$436,000
-23.0%
3,247
-7.2%
0.01%
-20.0%
Q2 2021$566,0003,4980.01%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders